321 related articles for article (PubMed ID: 9591854)
21. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
[TBL] [Abstract][Full Text] [Related]
22. [Changes in transitory evoked otoacoustic emissions in chemotherapy with cisplatin and 5FU].
Beck A; Maurer J; Welkoborsky HJ; Mann W
HNO; 1992 Apr; 40(4):123-7. PubMed ID: 1601678
[TBL] [Abstract][Full Text] [Related]
23. [Distortion product of otoacoustic emissions in normal hearing and sensorineural hearing loss].
Schlögel H; Stephan K; Böheim K; Welzl-Müller K
HNO; 1995 Jan; 43(1):19-24. PubMed ID: 7890546
[TBL] [Abstract][Full Text] [Related]
24. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
25. Transient evoked otoacoustic emissions and contralateral suppressions in children with auditory listening problems.
Yalçinkaya F; Yilmaz ST; Muluk NB
Auris Nasus Larynx; 2010 Feb; 37(1):47-54. PubMed ID: 19411150
[TBL] [Abstract][Full Text] [Related]
26. Ototoxic impact of cisplatin in pediatric oncology patients.
Berg AL; Spitzer JB; Garvin JH
Laryngoscope; 1999 Nov; 109(11):1806-14. PubMed ID: 10569412
[TBL] [Abstract][Full Text] [Related]
27. Screening for hearing loss and middle-ear effusion in school-age children, using transient evoked otoacoustic emissions: a feasibility study.
Georgalas C; Xenellis J; Davilis D; Tzangaroulakis A; Ferekidis E
J Laryngol Otol; 2008 Dec; 122(12):1299-304. PubMed ID: 18423079
[TBL] [Abstract][Full Text] [Related]
28. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
[TBL] [Abstract][Full Text] [Related]
29. Hearing loss in Turner syndrome.
Morimoto N; Tanaka T; Taiji H; Horikawa R; Naiki Y; Morimoto Y; Kawashiro N
J Pediatr; 2006 Nov; 149(5):697-701. PubMed ID: 17095347
[TBL] [Abstract][Full Text] [Related]
30. Interactive effects of the middle ear pathology and the associated hearing loss on transient-evoked otoacoustic emission measures.
Koike KJ; Wetmore SJ
Otolaryngol Head Neck Surg; 1999 Sep; 121(3):238-44. PubMed ID: 10471864
[TBL] [Abstract][Full Text] [Related]
31. Extended high-frequency hearing loss following the first episode of otitis media.
Cordeiro FP; da Costa Monsanto R; Kasemodel ALP; de Almeida Gondra L; de Oliveira Penido N
Laryngoscope; 2018 Dec; 128(12):2879-2884. PubMed ID: 30194735
[TBL] [Abstract][Full Text] [Related]
32. Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study.
Littman TA; Magruder A; Strother DR
J Am Acad Audiol; 1998 Aug; 9(4):257-62. PubMed ID: 9733234
[TBL] [Abstract][Full Text] [Related]
33. Audiological findings in Williams syndrome: a study of 69 patients.
Barozzi S; Soi D; Comiotto E; Borghi A; Gavioli C; Spreafico E; Gagliardi C; Selicorni A; Forti S; Ambrosetti U; Cesarani A; Brambilla D
Am J Med Genet A; 2012 Apr; 158A(4):759-71. PubMed ID: 22411878
[TBL] [Abstract][Full Text] [Related]
34. [Early detection of cisplatin-induced ototoxicity using evoked otoacoustic emissions].
Plinkert PK; Kröber S
Laryngorhinootologie; 1991 Sep; 70(9):457-62. PubMed ID: 1930486
[TBL] [Abstract][Full Text] [Related]
35. Effect of middle-ear effusion on otoacoustic emissions.
Yeo SW; Park SN; Park YS; Suh BD
J Laryngol Otol; 2002 Oct; 116(10):794-9. PubMed ID: 12437833
[TBL] [Abstract][Full Text] [Related]
36. Maturation of the occlusion effect: a bone conduction auditory steady state response study in infants and adults with normal hearing.
Small SA; Hu N
Ear Hear; 2011; 32(6):708-19. PubMed ID: 21617531
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
38. [Transitory evoked otoacoustic emissions in isolated high frequency, low frequency and middle frequency hearing].
Mathis A; De Min N; Arnold W
HNO; 1991 Feb; 39(2):55-60. PubMed ID: 2032875
[TBL] [Abstract][Full Text] [Related]
39. Age-related changes in evoked otoacoustic emission in normal-hearing ears.
O-Uchi T; Kanzaki J; Satoh Y; Yoshihara S; Ogata A; Inoue Y; Mashino H
Acta Otolaryngol Suppl; 1994; 514():89-94. PubMed ID: 8073895
[TBL] [Abstract][Full Text] [Related]
40. Application of transient evoked otoacoustic emissions to pediatric populations.
Norton SJ
Ear Hear; 1993 Feb; 14(1):64-73. PubMed ID: 8383069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
